Artificial Intelligence In Epidemiology Market Analysis, Scope And Growth 2025 To 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How has the artificial intelligence in epidemiology grown historically, and what trends indicate future expansion?
The artificial intelligence in epidemiology market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.84 billion in 2025 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to emergence of big data, globalization and travel, public health surveillance needs, outbreak response challenges, emergence of novel pathogens

The artificial intelligence in epidemiology market size is expected to see exponential growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to data integration challenges, population growth, global health security investments, digital health adoption, one health approach, digital contact tracing. Major trends in the forecast period include advancements in computational power, technological innovations in data collection, collaboration with technology companies, real-time data sharing platforms, advancements in ai algorithms, advancements in remote sensing technologies, blockchain for epidemiological data security.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12687&type=smp

Which key factors are driving the expansion of the artificial intelligence in epidemiology industry?
The growing burden of chronic diseases is expected to propel the growth of artificial intelligence in the epidemiology market going forward. Chronic disease refers to a health condition or disease that is persistent or long-lasting in its effects, usually lasting for three months or longer, and may get worse over time. AI plays a significant role in various aspects of chronic disease epidemiology, including risk prediction, disease progression modeling, early detection, and diagnosis. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases are responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans each year. Therefore, the growing burden of chronic diseases is expected to propel the growth of artificial intelligence in the epidemiology market.

How is the artificial intelligence in epidemiology market segmented by product, application, and end-user?
The artificial intelligence in epidemiology market covered in this report is segmented –

1) By Component: Software, Services
2) By Deployment: Web-Based, Cloud-Based
3) By Application: Infection Prediction And Forecasting, Disease And Syndromic Surveillance
4) By End-Use: Government And State Agencies, Research Laboratories, Pharmaceutical And Biotechnology Companies, Healthcare Providers

Subsegments:
1) By Software: Data Analytics Platforms, Predictive Modeling Tools, Geographic Information Systems (GIS), Surveillance Systems, Reporting And Visualization Tools
2) By Services: Consulting Services, Implementation And Integration Services, Data Management And Support Services, Training And Capacity Building Services

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-epidemiology-global-market-report

What future trends will impact the direction of the artificial intelligence in epidemiology industry?
Specialized AI-based technologies in disease management are a key trend gaining popularity in the artificial intelligence in epidemiology market. Major companies operating in the artificial intelligence in epidemiology market are concentrating on creating innovative technologies, such as AI-driven imaging platforms for disease management, to sustain their position in the market. For instance, in April 2023, Twinn.health, a US-based company engaged in fitness, AI, and machine learning, launched an AI-driven imaging platform for the early detection of age-related diseases. The new platform is the first to incorporate magnetic resonance imaging (MRI) data for the risk evaluation of frailty. It is a potent tool for early intervention and prevention since it detects chronic age-related disorders earlier than conventional molecular signals and helps manage these conditions at an early stage.

Which leading companies are dominating the artificial intelligence in epidemiology market landscape?
Major companies operating in the artificial intelligence in epidemiology market include Apple Inc., Alphabet Inc., Microsoft Corporation, Facebook Inc., Roche Holding AG, Pfizer Inc., Johnson & Johnson Services Inc., Amazon Web Services Inc., General Electric Company, Google LLC, Intel Corporation, IBM Corporation, Merck & Co. Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca PLC, Oracle Corporation, GlaxoSmithKline plc, NVIDIA Corporation, Bayer Healthcare, Siemens Healthineers AG, Cogniant Technology Solutions Corporation, Koninklijke Philips N.V., SAS Institute Inc., Epic Systems Corporation, Cerner Corporation, eClinicalWorks LLC, Meditech, Komodo Health, Metabiota Inc.

Which geographic areas are expected to offer the highest growth opportunities in theartificial intelligence in epidemiology market?
North America was the largest region in the artificial intelligence in epidemiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can Companies Use The Artificial Intelligence In Epidemiology Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12687

Need Customized Data On Artificial Intelligence In Epidemiology Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=12687&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company